Skip to main navigation
Skip to search
Skip to main content
Northern Arizona University Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Present and future therapeutic strategies for melioidosis and glanders
D. Mark Estes
, Steven W. Dow
, Herbert P. Schweizer
, Alfredo G. Torres
Research output
:
Contribution to journal
›
Review article
›
peer-review
93
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Present and future therapeutic strategies for melioidosis and glanders'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antibiotic Discovery
50%
Antibiotic Therapy
50%
Bioterrorism Agent
50%
Burkholderia Mallei
50%
Burkholderia Pseudomallei
50%
Causative Agents
50%
Destructive Impact
50%
Diabetic
50%
Future Therapeutics
100%
Genome Sequencing
50%
Glanders
100%
Gram-negative Pathogens
50%
Growing Population
50%
High Mortality Rate
50%
Malicious Use
50%
Malleus
100%
Mandatory Vaccines
50%
Melioidosis
100%
Modern History
50%
New Therapeutics
50%
Novel Therapeutics
50%
Opportunistic Infections
50%
Prophylactic Use
50%
Pseudomallei
100%
Public Health
50%
Severe Infection
50%
Target Identification
50%
Therapeutic Strategies
100%
Therapeutic Use
50%
Medicine and Dentistry
Antibiotic Therapy
25%
Antiinfective Agent
25%
Burkholderia mallei
25%
Burkholderia pseudomallei
25%
Diabetes Mellitus
25%
Disease
50%
Drug Therapy
25%
Glanders
100%
Infection
25%
Malleus
50%
Melioidosis
100%
Mortality Rate
25%
Opportunistic Infection
25%
Pathogen
100%
Public Health
25%
Target Identification
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antibiotic Therapy
25%
Antiinfective Agent
25%
Burkholderia mallei
25%
Burkholderia pseudomallei
25%
Diabetes Mellitus
25%
Disease
50%
Drug Discovery
25%
Glanders
100%
Infection
25%
Infectious Agent
100%
Melioidosis
100%
Mortality Rate
25%
Opportunistic Infection
25%
Target Identification
25%
Therapeutic Use
25%
Immunology and Microbiology
Burkholderia mallei
25%
Burkholderia pseudomallei
25%
Infectious Agent
100%
Mortality Rate
25%
Opportunistic Infection
25%
Vaccine Efficacy
25%